Check Before You Invest : Nidan Laboratories And Healthcare Ltd

Snapshot

Q.1 Which industry/sub-sector does Nidan Laboratories And Healthcare Ltd belong to?

Nidan Laboratories And Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.2 Is Nidan Laboratories And Healthcare Ltd a good quality company?

Nidan Laboratories And Healthcare Ltd is a quality company, based on a 7-year financial track record.

Q.3 Is Nidan Laboratories And Healthcare Ltd undervalued or overvalued?

Nidan Laboratories And Healthcare Ltd appears Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Nidan Laboratories And Healthcare Ltd a good buy now?

Nidan Laboratories And Healthcare Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd revenue growth is 1.5% for FY-2025, which is below its 5-year CAGR of 2.76%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Return on capital employed is 6.21% for FY-2025, which is below its 5-year historical median of 8.5%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Return on Asset is 2.41%, which is below its 5-year historical median of 3.76%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Return on equity is 2.94% for FY-2025, which is below its 5-year historical median of 5.23%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Cash conversion cycle is 0 days, below its 5-year historical median of 43 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.3	0.3
ROE	2.94	5.23
ROCE	6.21	8.5
Cash Conversion Cycle	-	43 days

Q.6 Gross Profit margin of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Gross profit margin which is the profit after deduction of direct costs, is 21.1% for FY-2025, which is below its 5-year median of 29%, indicating decreasing margins.

Q.7 Operating Profit Margin of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 20.64% for FY-2025, which is below its 5-year median of 28.04% indicating decreasing margins.

Q.8 Net Profit Margin of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Net Profit Margin is 8.06% for FY-2025, is below with its 5-year median of 8.98%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	21.1	29
Operating Profit Margin	20.64	28.04
Net Profit Margin	8.06	8.98

Q.9 Debt to Equity ratio of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Debt-to-Equity ratio is 0.16, which is lower with the industry average of 0.25, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Nidan Laboratories And Healthcare Ltd?

Nidan Laboratories And Healthcare Ltd Debt to cash flow from operations is 4.88, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nidan Laboratories And Healthcare Ltd?

Promoters hold 57.04% of the Nidan Laboratories And Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nidan Laboratories And Healthcare Ltd vs industry peers?

Nidan Laboratories And Healthcare Ltd revenue CAGR is 2.76%, compared to the industry median CAGR of 10.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	1.5	10.3
Gross Profit Growth	-26.3	18
Operating Profit Growth	-21.4	15.4
Net Profit Growth	0	22.8

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.3	0.73
ROE	2.94	13.91
ROCE	6.21	17.77
Cash Conversion Cycle (days)	0.34	4

Valuation & price assessment

Q.1 Stock return of Nidan Laboratories And Healthcare Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -30.46% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-30.5%	-22.8%

Q.3 Valuation ratios of Nidan Laboratories And Healthcare Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	10.58	16.51	36.99
Price to Book	0.31	0.69	3.61
Price to Sales	0.85	1.90	4.24
EV to EBITDA	4.12	5.45	17.74

Check more companies

1. Aster DM Healthcare

2. Global Health

3. Krishna Inst.Medi

4. Dr. Lal Pathlabs

5. Dr. Agarwals Health

6. RainbowChildrenS Med

7. Vijaya Diagnostic

8. Park Medi World

9. Metropolis Health.

10. HealthcareGlobal

Check trending companies

1. Info Edge (India) Ltd.

2. Tata Motors Passenger Vehicles Ltd.

3. Bajaj Finserv Ltd.

4. Ultratech Cement Ltd.

5. Titan Company Ltd.